ImpediMed

ImpediMed’s SOZO®️ Digital Health Platform is the only FDA-Cleared bioimpedance spectroscopy (BIS) technology that non-invasively measures fluid status and tissue composition in just 30 seconds. Because fluid shifts can be one of the first and most sensitive signs of change in the body, BIS enables clinicians to monitor key health indicators such as skeletal muscle mass and fat mass, providing them with real-time, whole-body insights to support lifestyle medicine interventions and deliver personalized care.